tradingkey.logo
tradingkey.logo
Search

Optimi Health Ord Shs

OPTH
Add to Watchlist
2.250USD
+0.070+3.21%
Close 11-13 16:00(ET)
12.89MMarket Cap
0.00P/E TTM

About Optimi Health Ord Shs Company

Optimi Health Corp. is a commercial-stage pharmaceutical company. The Company focuses on manufacturing and distributing good manufacturing practices (GMP) grade psychedelic drug products for mental health therapies. As a Health Canada-licensed pharmaceutical manufacturer, the Company produces validated Methylenedioxymethamphetamine hydrochloride (MDMA) and botanical psilocybin drug products at its GMP-compliant facilities in British Columbia, Canada. It supplies both active pharmaceutical ingredients and finished dosage forms to regulated clinical and therapeutic programs internationally, with products prescribed to patients in Australia under the country's authorized prescriber scheme and accessible in Canada through the special access program. With its vertically integrated approach, the Company owns and operates two purpose-built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada.

Optimi Health Ord Shs Profile

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of Optimi Health Ord Shs

Name
Name/Position
Position
Shareholding
Change
Mr. John James Wilson
Mr. John James Wilson
Chairman of the Board
Chairman of the Board
274.58K
+96.03%
Mr. Jason Mosberian
Mr. Jason Mosberian
Independent Director
Independent Director
875.00
+52.23%
Mr. Bryan Safarik
Mr. Bryan Safarik
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Jacob Safarik
Mr. Jacob Safarik
Interim Chief Financial Officer, Director
Interim Chief Financial Officer, Director
--
--
Mr. Dane Stevens
Mr. Dane Stevens
Chief Executive Officer, Chief Marketing Officer, Corporate Secretary, Director
Chief Executive Officer, Chief Marketing Officer, Corporate Secretary, Director
--
--
Dr. Michael Blough, Ph.D.
Dr. Michael Blough, Ph.D.
Chief Clinical Development Officer
Chief Clinical Development Officer
--
--
Ms. Melanie Pump
Ms. Melanie Pump
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. John James Wilson
Mr. John James Wilson
Chairman of the Board
Chairman of the Board
274.58K
+96.03%
Mr. Jason Mosberian
Mr. Jason Mosberian
Independent Director
Independent Director
875.00
+52.23%
Mr. Bryan Safarik
Mr. Bryan Safarik
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Jacob Safarik
Mr. Jacob Safarik
Interim Chief Financial Officer, Director
Interim Chief Financial Officer, Director
--
--
Mr. Dane Stevens
Mr. Dane Stevens
Chief Executive Officer, Chief Marketing Officer, Corporate Secretary, Director
Chief Executive Officer, Chief Marketing Officer, Corporate Secretary, Director
--
--
Dr. Michael Blough, Ph.D.
Dr. Michael Blough, Ph.D.
Chief Clinical Development Officer
Chief Clinical Development Officer
--
--

FAQs

Who are the top five shareholders of Optimi Health Ord Shs?

The top five shareholders of Optimi Health Ord Shs are: Mr. John James Wilson
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.